BLOG

Set up a new diagnostic hub in Milan: Sentinel Diagnostics’ project to compete in the diagnostic devices market

Set up a new diagnostic hub in Milan: Sentinel Diagnostics’ project to compete in the diagnostic devices market

Sentinel Diagnostics’ success is the result of ongoing investments to improve the development and manufacturing stages of our diagnostic devices, which are used to perform diagnostic test around the world. Here the translation of the recent article, published in the Italian newspaper, Corriere della Sera, on July 20th 2021, to retrace the results achieved and […]

READ MORE "Set up a new diagnostic hub in Milan: Sentinel Diagnostics’ project to compete in the diagnostic devices market"




SENTINEL DIAGNOSTICS TO ACQUIRE G6PDH PRODUCTS’ MANUFACTURING AND DISTRIBUTION RIGHTS FROM BE BIOTECH Srl

SENTINEL DIAGNOSTICS TO ACQUIRE G6PDH PRODUCTS’ MANUFACTURING AND DISTRIBUTION RIGHTS FROM BE BIOTECH Srl

Sentinel Diagnostics (Sentinel CH S.p.A.) is pleased to announce that on June 18th has signed an agreement with BE Biotech Srl to acquire the rights to manufacture and distribute the G6PDH Products. The two companies has defined a transition plan to ensure the continuity and quality of the service offered by BE Biotech Srl and […]

READ MORE "SENTINEL DIAGNOSTICS TO ACQUIRE G6PDH PRODUCTS’ MANUFACTURING AND DISTRIBUTION RIGHTS FROM BE BIOTECH Srl"








Sentinel promotes experts discussion on Covid-19 testing

Sentinel promotes experts discussion on Covid-19 testing

With the effort to support scientific highly valuable discussion around Covid-19 topics, Sentinel Diagnostics is proud to organize a round table discussion on June, 10th: “LOOKING BEYOND THE COVID-19 PANDEMIC: LESSONS LEARNED AND FUTURE PERSPECTIVE ON DIAGNOSIS AND EPIDEMIOLOGICAL STUDIES” Our guests, dr Fulvio Ferrara, Head of  Department of Laboratory Medicine, Pathology and Molecular Genetics and […]

READ MORE "Sentinel promotes experts discussion on Covid-19 testing"








Sentinel Diagnostics announces the launch of the new quantitative serological kits COVID-19

Sentinel Diagnostics announces the launch of the new quantitative serological kits COVID-19

As Sentinal Diagnostics, we are committed to support healthcare professionals to fight COVID-19 pandemic, thus we have developed two new kits to detect the total antibodies (IgA, IgG and IgM) against Spike and Nucleocapside proteins of SARS-CoV-2. COVID-19 Anti-S1 Total Ab and COVID-19 Anti-NC Total Ab assays are In Vitro Diagnostic tests, for quantitative and […]

READ MORE "Sentinel Diagnostics announces the launch of the new quantitative serological kits COVID-19"




UK, South African and Brazilian variants SARS-CoV-2 mutations don’t affects the targets of Sentinel Diagnostics’ kits

UK, South African and Brazilian variants SARS-CoV-2 mutations don’t affects the targets of Sentinel Diagnostics’ kits

As Sentinel Diagnostics we are constantly working from the beginning of the COVID-19 pandemia providing high quality test for SARS-CoV-2 detection. Recently new virus variants appeared, such as the UK variant (B.1.1.7), the South African variant (B.1.351), and the Brazilian variant (P.1). This raised concerns regarding their potential increased virulence and resistance to neutralizing Ab. […]

READ MORE "UK, South African and Brazilian variants SARS-CoV-2 mutations don’t affects the targets of Sentinel Diagnostics’ kits"




Forbes Italia applauds Sentinel Diagnostics as champion of the Italian business

Forbes Italia applauds Sentinel Diagnostics as champion of the Italian business

Sentinel Diagnostics is part of the successful companies celebrated by the magazine Forbes Italia, regarding the second edition of the Imprese Vincenti Award (Banca Intesa Sanpaolo). Almost 4.000 companies have applied and, after a careful selection, the committee has chosen the 144 winning companies, which are the best expression of the Italian economic fabric, with revenues […]

READ MORE "Forbes Italia applauds Sentinel Diagnostics as champion of the Italian business"